<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR106">
 <label>106.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nannetti</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Massari</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Mercorelli</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Bertagnin</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Desantis</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Pal√π</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Tabarrini</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Loregian</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance</article-title>
  <source>Antivir Res</source>
  <year>2019</year>
  <volume>165</volume>
  <fpage>55</fpage>
  <lpage>64</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2019.03.003</pub-id>
  <?supplied-pmid 30885750?>
  <pub-id pub-id-type="pmid">30885750</pub-id>
 </element-citation>
</ref>
